ELVA vs. RAPT

Last updated Jun 4, 2026

ELVA (Electrovaya Inc. Common Shares) and RAPT (RAPT Therapeutics, Inc.) are both stocks. ELVA operates in Electrical Equipment & Parts (Industrials), while RAPT operates in Biotechnology (Healthcare). At a 0.15 correlation, their price movements are largely independent.

Performance

ELVA vs. RAPT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Electrovaya Inc. Common Shares (ELVA) and RAPT Therapeutics, Inc. (RAPT). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

ELVA

• 1D: -7.99%
• 1M: 19.37%
• YTD: 42.78%
• 6M: 129.27%
• 1Y: 237.27%
• 3Y*: 48.42%
• 5Y*: 14.03%
• 10Y*: 4.45%

RAPT

• 1D: —
• 1M: —
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

ELVA vs. RAPT - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019
ELVA Electrovaya Inc. Common Shares	42.78%	218.55%	-18.95%	-17.30%	2.78%	-38.98%	686.67%	-6.25%
RAPT RAPT Therapeutics, Inc.	71.30%	167.96%	-93.64%	25.51%	-46.09%	85.97%	-28.47%	112.38%

Correlation

The correlation between ELVA and RAPT is 0.03, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.03
Correlation (3Y) Calculated over the trailing 3-year period	0.12
Correlation (5Y) Calculated over the trailing 5-year period	0.15
Correlation (All Time) Calculated using the full available price history since Nov 1, 2019	0.15

The correlation between ELVA and RAPT shifts across timeframes, from 0.03 (1 year) to 0.15 (all time), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap ELVA : $582.72M RAPT : $1.56B
EPS ELVA : $0.11 RAPT : -$3.92
PB Ratio ELVA : 9.25 RAPT : 10.29
Total Revenue (TTM) ELVA : $70.74M RAPT : $0.00
Gross Profit (TTM) ELVA : $22.01M RAPT : -$200.00K
EBITDA (TTM) ELVA : $6.86M RAPT : -$108.01M

Return for Risk

ELVA vs. RAPT — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ELVA

ELVA Risk / Return Rank: 91
ELVA Sharpe Ratio Rank: 94
ELVA Sortino Ratio Rank: 89
ELVA Omega Ratio Rank: 87
ELVA Calmar Ratio Rank: 92
ELVA Martin Ratio Rank: 91

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ELVA vs. RAPT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Electrovaya Inc. Common Shares (ELVA) and RAPT Therapeutics, Inc. (RAPT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	ELVA	RAPT	Difference
Sharpe ratio Return per unit of total volatility	2.86	—	—
Sortino ratio Return per unit of downside risk	3.15	—	—
Omega ratio Gain probability vs. loss probability	1.39	—	—
Calmar ratio Return relative to maximum drawdown	5.38	—	—
Martin ratio Return relative to average drawdown	12.89	—	—
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

Sharpe Ratios by Period

	ELVA	RAPT	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	2.86	—	—
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.20	—	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.05	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.19	—	—

Drawdowns

Drawdown Indicators

	ELVA	RAPT	Difference
Max Drawdown Largest peak-to-trough decline	-96.90%	—	—
Max Drawdown (1Y) Largest decline over 1 year	-44.42%	—	—
Max Drawdown (3Y) Largest decline over 3 years	-64.19%	—	—
Max Drawdown (5Y) Largest decline over 5 years	-67.83%	—	—
Max Drawdown (10Y) Largest decline over 10 years	-96.90%	—	—
Current Drawdown Current decline from peak	-29.96%	—	—
Average Drawdown Average peak-to-trough decline	-73.75%	—	—
Ulcer Index Depth and duration of drawdowns from previous peaks	18.50%	—	—

Volatility

Volatility by Period

	ELVA	RAPT	Difference
Volatility (1M) Calculated over the trailing 1-month period	29.36%	—	—
Volatility (6M) Calculated over the trailing 6-month period	62.89%	—	—
Volatility (1Y) Calculated over the trailing 1-year period	84.08%	—	—
Volatility (5Y) Calculated over the trailing 5-year period, annualized	68.98%	—	—
Volatility (10Y) Calculated over the trailing 10-year period, annualized	86.14%	—	—

Dividends

ELVA vs. RAPT - Dividend Comparison

Neither ELVA nor RAPT has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both ELVA and RAPT in my portfolio?

ELVA and RAPT have a correlation of 0.03, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.